Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Medios AG
  6. News
  7. Summary
    ILM1   DE000A1MMCC8

MEDIOS AG

(ILM1)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PRESS RELEASE: Medios AG: Deutsche Bank initiates coverage on Medios with a 'Buy' recommendation and a price target of EUR50.00

04/19/2021 | 04:09am EDT
DGAP-News: Medios AG / Key word(s): Study/Research Update 
Medios AG: Deutsche Bank initiates coverage on Medios with a 'Buy' recommendation and a price target of EUR50.00 
2021-04-19 / 10:08 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Press Release 
Medios AG: Deutsche Bank initiates coverage on Medios with a "Buy" recommendation and a price target of EUR50.00 
Berlin, 19 April 2021 - Deutsche Bank has initiated coverage on Medios AG today and issued a "Buy" recommendation for 
the shares of the leading provider of Specialty Pharma solutions in Germany. The price target amounts to EUR50.00 per 
share, accordingly. The Medios share price currently stands at EUR36.00 (Xetra closing on 16 April 2021). In addition to 
Deutsche Bank, Medios continues to be covered by Berenberg, Jefferies, Kepler Cheuvreux, Metzler Capital Markets and 
Warburg. 
=------------------ 
About Medios AG 
Medios AG is the leading provider of Specialty Pharma solutions in Germany. As a competence partner and expert, Medios 
covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of 
patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies. 
Medios AG is Germany's first listed Specialty Pharma company and member of the SDAX selection index (Prime Standard) 
(ISIN: DE000A1MMCC8). 
www.medios.ag 
Contact 
Claudia Nickolaus 
Head of Investor & Public Relations 
Medios AG 
Heidestraße 9 | 10557 Berlin | Germany 
P +49 30 232 566 800 
c.nickolaus@medios.ag 
www.medios.ag 
Nikolaus Hammerschmidt 
Senior Consultant Investor & Public Relations 
Kirchhoff Consult AG 
Borselstraße 20 | 22765 Hamburg | Germany 
P +49 40 609 186 18 
nikolaus.hammerschmidt@kirchhoff.de 
www.kirchhoff.de 
Disclaimer 
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future 
results may significantly deviate from currently expected results, specifically due to various risk factors and 
uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, 
uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no 
responsibility whatsoever for updating the forward-looking statements contained in this notification. 
=---------------------------------------------------------------------------------------------------------------------- 
2021-04-19 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Medios AG 
              Heidestraße 9 
              10557 Berlin 
              Germany 
Phone:        +49 30 232 566 - 800 
Fax:          +49 30 232 566 - 801 
E-mail:       ir@medios.ag 
Internet:     www.medios.ag 
ISIN:         DE000A1MMCC8 
WKN:          A1MMCC 
Indices:      SDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf 
EQS News ID:  1185981 
 
End of News   DGAP News Service 
=------------ 

1185981 2021-04-19

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1185981&application_name=news 
 

(END) Dow Jones Newswires

April 19, 2021 04:08 ET (08:08 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DEUTSCHE BANK AG 3.03% 10.818 Delayed Quote.20.89%
DJ INDUSTRIAL 0.44% 35084.53 Delayed Quote.14.55%
MEDIOS AG 3.76% 34.5 Delayed Quote.-7.75%
SDAX 0.75% 16565.73 Delayed Quote.12.20%
SDAX PERFORMANCE INDEX 9:00-20:00 0.62% 16508.05 Delayed Quote.11.11%
All news about MEDIOS AG
07/02MEDIOS AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
06/18MEDIOS AG : Preliminary announcement of the publication of financial reports acc..
EQ
06/15MEDIOS AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
06/10PRESS RELEASE : Medios AG holds successful 2021 Annual General Meeting - Focus o..
DJ
06/10MEDIOS : holds successful 2021 Annual General Meeting - Focus on Corporate Gover..
EQ
05/12MEDIOS : Buy rating from Berenberg
MD
05/11MEDIOS : Warburg Research keeps its Buy rating
MD
05/11MEDIOS : starts the 2021 financial year with a record quarter
EQ
05/11PRESS RELEASE : Medios AG starts the 2021 financial year with a record quarter
DJ
05/11Medios AG Confirms Earnings Guidance for the Full-Year 2021
CI
More news
Financials
Sales 2021 1 236 M 1 468 M 1 468 M
Net income 2021 15,8 M 18,8 M 18,8 M
Net Debt 2021 9,08 M 10,8 M 10,8 M
P/E ratio 2021 41,0x
Yield 2021 -
Capitalization 699 M 831 M 830 M
EV / Sales 2021 0,57x
EV / Sales 2022 0,49x
Nbr of Employees 307
Free-Float 71,1%
Chart MEDIOS AG
Duration : Period :
Medios AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIOS AG
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 34,50 €
Average target price 47,75 €
Spread / Average Target 38,4%
EPS Revisions
Managers and Directors
Matthias A. Gńrtner Chief Executive Officer
Yann Samson Chairman-Supervisory Board
Mi Young Miehler Chief Operating Officer
Klaus Bu▀ Member-Supervisory Board
Joachim Messner Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
MEDIOS AG-7.75%831
WALGREENS BOOTS ALLIANCE, INC.17.95%40 689
JD HEALTH INTERNATIONAL INC.-43.20%34 930
MCKESSON CORPORATION18.00%31 741
CARDINAL HEALTH, INC.11.37%17 406
HUADONG MEDICINE CO., LTD32.12%9 510